Preclinical and Clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of INFANTILE HEMIPLEGIA in childre
Phase 2
- Conditions
- Health Condition 1: G819- Hemiplegia, unspecified
- Registration Number
- CTRI/2022/11/046972
- Lead Sponsor
- DR M MUKILA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Stiffness and weekness in muscles on one side of the body
Pain
Muscle spasm
Delayed milestones
Difficulty with walking and balance
Exclusion Criteria
Children below 2 years
Children above 12 years
Congenoital cardiac failure
Infantile hemiplegia with associated congenital abnormalities
Infantile hemiplegia with co-morbidities like mental retardation and muscular dystrophy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To access the effectiveness of PARANGI KASAYAM AND VARMAM THERAPHY in the management of BALAR PAKKA VATHAM in children by using GMFCS, MACS, EDACS rating scale to improve their mobility and regain their functional independenceTimepoint: 48 DAYS
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil